Clinical Trial

Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult Patients

Study acronym: INTACT-HIP
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The INTACT-HIP trial study will evaluate feasibility of conducting a randomized, double-blinded controlled trial comparing postoperative treatment with intravenous (IV) acetaminophen versus oral acetaminophen, in older adults undergoing hip fracture surgery. The results of this feasibility trial will be used to inform designing a larger, multi-center, randomized controlled trial to assess the efficacy of IV acetaminophen compared to oral acetaminophen to reduce delirium and improve other clinical and patient-centered outcomes after hip fracture surgery. It will randomize 42 older adults to receive either oral or IV acetaminophen after hip fracture surgery.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-12-30 -> 2026-08-30 2026-07-24
minor Completion pushed: 2026-06-30 -> 2026-12-30 2026-07-24
Trial Details
NCT Number NCT05425355
Lead Sponsor University Health Network, Toronto
Conditions Hip-fracture, Surgery
Enrollment 42 participants
Start Date 2023-01-23
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-23